These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3607806)

  • 1. A comparison of intravenous elantan and frusemide in patients with chronic cardiac failure.
    Hutton I; McGhie AI; Martin W; Tweddel AC
    Cardiology; 1987; 74 Suppl 1():65-8. PubMed ID: 3607806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-ranging study of isosorbide-5-mononitrate in chronic congestive heart failure treated with diuretics and angiotensin-converting enzyme inhibitor.
    Debbas N; Woodings D; Marks C; Bhans A; Jubber A; Dews I; Stephens J; Vandenburg M
    Am J Cardiol; 1988 Mar; 61(9):28E-30E. PubMed ID: 2831702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
    Cotter G; Metzkor E; Kaluski E; Faigenberg Z; Miller R; Simovitz A; Shaham O; Marghitay D; Koren M; Blatt A; Moshkovitz Y; Zaidenstein R; Golik A
    Lancet; 1998 Feb; 351(9100):389-93. PubMed ID: 9482291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.
    Gammage MD; Murray RG; Littler WA
    Eur J Clin Pharmacol; 1986; 29(6):639-43. PubMed ID: 3709607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Z Kardiol; 1983; 72 Suppl 3():141-6. PubMed ID: 6666215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
    Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
    Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.
    Nelson GI; Ahuja RC; Silke B; Okoli RC; Hussain M; Taylor SH
    Eur Heart J; 1983 Oct; 4(10):706-11. PubMed ID: 6653580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isosorbide 5-mononitrate in the treatment of left ventricular failure following acute myocardial infarction.
    Murray RG; Gammage MD
    Cardiology; 1987; 74 Suppl 1():58-9. PubMed ID: 3607805
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Lancet; 1983 Apr; 1(8327):730-3. PubMed ID: 6132082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
    Halon DA; Rosenfeld T; Hardoff R; Lewis BS
    Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
    Schneeweiss A
    Am J Cardiol; 1988 Mar; 61(9):19E-21E. PubMed ID: 3126632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of oral and intravenous isosorbide mononitrate (5-MNi) in the acute phase of myocardial infarction].
    Rezende M
    Rev Port Cardiol; 1993 Mar; 12 Suppl 1():I35-8. PubMed ID: 8499118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
    Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
    Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual isosorbide dinitrate in severe congestive heart failure.
    Markiewicz W; Rochman J; Peled B
    Cardiology; 1981; 67(3):172-9. PubMed ID: 7273045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].
    Jansen W; Osterspey A; Tauchert M; Schmid G; Schell U; Fuchs M; Hombach V; Hilger HH
    Dtsch Med Wochenschr; 1982 Oct; 107(40):1499-506. PubMed ID: 7117166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effects of intravenous isosorbide dinitrate in acute myocardial infarct].
    Rezakovic D; Bloch A; Rutishauser W; Pavicic L; Stalec J
    Schweiz Med Wochenschr; 1982 Nov; 112(48):1729-35. PubMed ID: 7178874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.
    Wendt RL
    J Pharmacol Exp Ther; 1972 Mar; 180(3):732-42. PubMed ID: 4622308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.